SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-011129
Filing Date
2023-03-10
Accepted
2023-03-10 11:59:05
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K brhc10049597_8k.htm   iXBRL 8-K 23137
  Complete submission text file 0001140361-23-011129.txt   157487

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rckt-20230310.xsd EX-101.SCH 3877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20230310_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20230310_pre.xml EX-101.PRE 16052
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10049597_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 23722565
SIC: 2834 Pharmaceutical Preparations